Share Twitter LinkedIn Facebook Email Earn CME: https://naccme.com/program/7315 In this presentation from the ‘CAR-T for Lymphomas: Cultivating a Cure, Controlling a Crisis symposium, Nurse Rita M. Jakubowski provides an overview of CAR-T in lymphoma. © 2018 Imedex, an HMP Company
FDA Approves Adcetris / brentuximab vedotin + lenalidomide & rituximab in relapsed or refractory LBCL: Could This Change Standard Care? Lymphoma 2 Mins Read
2024 Update on Lymphoma Treatment: Navigating the Latest Advances – Elizabeth Brem, MD [38 Slides] Hodgkin Lymphoma 4 Mins Read
FDA Grants Accelerated Approval to Zanubrutinib (Brukinsa) for Relapsed or Refractory Follicular Lymphoma Lymphoma 2 Mins Read